Skip to content
← Lobby register
CT
NGO

Cancer Trials Ireland

🇪🇺 IRELANDRegistered 04/02 staff
Disclosed budget
€1,782,605
Meetings 12mo
0
Policy files
0
Accredited passes
0

Recent meetings

No recorded meetings with EU commissioners.

Mission & Goals

Our mission is to maximise cancer trial access and outcomes to prolong patient lives and expand cancer research in Ireland. Our vision is to be an indispensable all-Ireland hub for cancer trials, globally recognised for excellence in governance, collaboration and innovation in clinical research. We enable, support and oversee the running of over 100 cancer trials involving thousands of patients.

EU Legislative Interests

-Commission Stakeholder on Europe’s Beating Cancer Plan -European Parliament, Cancer Mission and EU Member States.

Communication Activities

Participation in Commission Stakeholder Contact Group on Europe’s Beating Cancer Plan

Interests Represented

Does not represent commercial interests

Member Of

Breast International Group (BIG) - disbanding in 2026, Eastern Cooperative Oncology (ECOG) and American College of Radiology Imaging Network (ACRIN) Research Group, European Network for Gynaecological Oncological Trials (ENGOT) Group, PrECOG - Sister Foundation of ECOG, European Organisation for Research and Treatment of Cancer (EORTC), European Thoracic Oncology Platform (ETOP) and International Breast Cancer Study Group (IBCSG), German Breast Group (GBG), Gynaecologic Oncology Group (GOG), National Surgical Adjuvant Breast and Bowel Project (NSABP),Swiss Cancer Institute (SCI, formally SAKK).

Organisation Members

Innovative Therapies for Children with Cancer (ITCC), National Cancer Research Network UK (CRUK), (incorporating Cancer Research UK, the Radiation Therapy Oncology Group (RTOG), European Society for Paediatric Oncology (SIOPE), Southwest Oncology Group (SWOG), Translational Research in Oncology (TRIO), Trans-Tasman Radiation Oncology Group (TROG), Canadian Clinical Trials Group (CCTG), Australian Gastrointestinal Trials Group (AGITG).